MedPath

Measuring the Impact of an Interdisciplinary Polypharmacy Clinic Within a Patient-centered Medical Home

Withdrawn
Conditions
Polypharmacy
Interventions
Other: interdisciplinary polypharmacy clinic visit
Registration Number
NCT02077725
Lead Sponsor
Ohio State University
Brief Summary

Title: Measuring the impact of an interdisciplinary polypharmacy clinic within a patient-centered medical home

Objectives:

The primary objective of this project will be to track the types of interventions made in an interdisciplinary polypharmacy clinic to improve medication regimens and medication burden. Polypharmacy has been well documented in the literature as a risk for medication errors, adverse drug events, and morbidity. Team visits, including complete medication reviews, by pharmacists and physicians within a National Committee for Quality Assurance (NCQA) tier 3 patient-centered medical home (PCMH) at an academic medical center, can improve medication regimens. Secondary objectives include (1) measuring each patient's quality of life at baseline and one month post-intervention and (2) tracking the cost of medication additions and discontinuations.

Methods:

Patients taking ten or more chronic medications will be identified for referral to the polypharmacy clinic from a report generated from the electronic medical record. The polypharmacy clinic will be staffed by a pharmacist and medical resident with oversight from an attending physician who specializes in geriatrics. Drug-related problems identified during the visit will be resolved and categorized based upon indication, efficacy, cost, safety, and compliance. The numbers and types of interventions made, both during the primary visit and anticipated in the future, will be tracked. The 12-item short form (SF-12) survey will also be administered at baseline and one month post intervention. The increase or decrease in cost for medications added and removed during these visits will be captured using the average wholesale prices.

Preliminary Results Using descriptive statistics, the types of drug-related problems identified and interventions made will be reported. Changes in quality of life and monthly medication costs will also be described.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients on 10 or more chronic medications
  • Age 18 or older
Exclusion Criteria
  • Non-English speaking patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Interdisciplinary polypharmacy clinicinterdisciplinary polypharmacy clinic visitPatients will be seen in the interdisciplinary polypharmacy clinic for a complete comprehensive medication review
Primary Outcome Measures
NameTimeMethod
Number and types of drug related problems identified1 year
Secondary Outcome Measures
NameTimeMethod
Cost of medication additions and discontinuations1 month
Assess quality of life at baseline and one month post polypharmacy clinic visit1 month

Trial Locations

Locations (1)

The Ohio State University Division of General Internal Medicine Martha Morehouse

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath